Moderate-to-severe plaque psoriasis; psoriatic arthritis; ankylosing spondylitis; hidradenitis suppurativa.
FDA-Approved Indications
Sorted by price, lowest first. Always verify eligibility and pricing directly with the manufacturer.
via Novartis Direct · Novartis
As little as $0/mo
Co-pay savings for commercially insured. Subject to annual co-pay benefit limit. Infusion admin support excludes RI and MA.
Eligibility
Commercial insurance required. Valid Rx. US and Puerto Rico only. Excluded: Medicare, Medicaid, TRICARE, VA, any federal/state plan.
Some benefits may not be available in: RI, MA
Last verified: Mar 2026
via Novartis Direct · Novartis
$0/mo for up to 2 years
Free Cosentyx subcutaneous injection for up to 2 years or until insurance approves coverage. Must appeal denial within 90 days of enrollment.
Eligibility
Private insurance required with prior authorization denial. Must appeal within 90 days. Subcutaneous only — IV infusion not eligible.
Last verified: Mar 2026
via Novartis Direct · Novartis
$1,717/mo
55% off list price. Pediatric dosing formulation. Same DTP terms as Program A. No expiry stated.
Eligibility
Valid US prescription required. US residents only (incl. territories). Cannot combine with any other Novartis offer.
May purchase at cash price. Cannot seek reimbursement or count toward deductible.
Last verified: Mar 2026
via Novartis Direct · Novartis
$3,434/mo
55% off list price ($8,492/mo list). Insurance cannot be used. Fulfilled through ASPN Pharmacies / Thrifty White. HSA/FSA accepted.
Eligibility
Valid US prescription required. US residents only (incl. territories). Cannot combine with any other Novartis offer. NPAF (no-cost PAP) available for patients who cannot afford cash price.
May purchase at cash price. Cannot seek reimbursement or count toward deductible.
Last verified: Mar 2026
Not sure which Cosentyx program fits your situation?
Find My Options